Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RGN-259 Ophthalmic Solutions for the Treatment of Dry Eye
NCT03937882Phase 3Completed
- Sponsor
- ReGenTree
- Start
- May 2019
- Primary completion
- Nov 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of timbetasin in dry eye syndrome (DED), sponsored by ReGenTree. Started May 2019; status: completed.
02
Drugs
timbetasin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT03937882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03937882.